Novartis to buy Takeda eye drug assets for $5.3 bn
Novartis AG agreed to buy eye disease medicines from Takeda Pharmaceutical Co for as much as $5.3 billion as the Japanese company moves to shed debt09-05-2019
09-05-2019
Novartis India Ltd - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sirs, Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the following shareholder has lost their share certificate, as per the information received from the Company's Registrar and Share Transfer Agent on May 09, 2019. Stop Transfer Date Folio No Name of Shareholder Certificate No. Distinctive No. No. of Shares Reason 08 May 2019 02036100 BHARAT M SHAH RAMILA B SHAH 9832 3724037 - 3724156 120 Lost By Holder Request you to take the same on record as required under the provisions of the said Regulation. Thanking you09-05-2019
Novartis India Ltd - 500672 - Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996
Dear Sir, Subject: Certificate pursuant to Regulation 74(5) of SEBI (Depository & Participants), Regulations 2018 With reference to the above subject, please find enclosed a Certificate under Regulation 74(5) of SEBI (Depository & Participants) Regulations, 2018 for the quarter ended March 31, 2019 received from M/s. Link Intime India Private Limited on April 27, 2019, the Registrar and Share Transfer Agent of the Company. Contents of the said letter are self-explanatory. You are requested to take note of the same in your records. Thanking you.07-05-2019
NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sirs, Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the following shareholder has lost her share certificate, as per the information received from the Company's Registrar and Share Transfer Agent on May 03, 2019. Stop Transfer Date Folio No Name of Shareholder Certificate No. Distinctive No. No. of Shares Reason 02 May 2019 02213184 NALINI PRAVINCHANDRA SHAH 18331 15528788 - 15528817 30 Lost By Holder Request you to take the same on record as required under the provisions of the said Regulation. Thanking you03-05-2019
Novartis India Ltd - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sirs, Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the following shareholders has lost their share certificate, as per the information received from the Company's Registrar and Share Transfer Agent on April 28, 2019. Stop Transfer Date Folio No Name of Shareholder Certificate No. Distinctive No. No. of Shares Reason 27 Apr 2019 A000822 ASHOK KUMAR HEER 429714 31864219 - 31864220 2 Lost By Holder 27 Apr 2019 02357666 TANUJA DHANG 25180 16265244 - 16265313 70 Lost By Holder Request you to take the same on record as required under the provisions of the said Regulation. Thanking you02-05-2019
NOVARTIS INDIA LTD. - 500672 - Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015
Dear Sirs, Pursuant to Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we enclose herewith a Certificate from a Practicing Company Secretary confirming that all certificates have been issued within thirty days of the date of lodgement for transfer, sub-division, consolidation, renewal, etc. for the half year ended March 31, 2019. Kindly take the same on your records. Thanking you.25-04-2019
Novartis India Ltd - 500672 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015 For Half Year Ended March 31, 2019
Dear Sirs, Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed the Compliance Certificate, for half year ended March 31, 2019. Thanking you.24-04-2019
Novartis India Ltd - 500672 - Shareholding for the Period Ended March 31, 2019
Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here18-04-2019
NOVARTIS INDIA LTD. - 500672 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Trivikram GudaDesignation :- Company Secretary and Compliance Officer18-04-2019
NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sirs, Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the following shareholder has lost his share certificate, as per the information received from the Company's Registrar and Share Transfer Agent on April 13, 2019. Stop Transfer Date Folio No Name of Shareholder Certificate No. Distinctive No. No. of Shares Reason 12 Apr 2019 02161923 LOMESH H SHAH 15765 4589238 - 4589327 90 Lost By Holder Request you to take the same on record as required under the provisions of the said Regulation. Thanking you15-04-2019